Search research articles
Contact Us
Filters
Showing results (111-120 of 120) with videos related to
Page
of 12
Sort By:
You have reached the last page of results.
This site can display upto 120 results.
Blood
|
November 26, 1999
A randomized, double-blind, placebo-controlled study with pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) as an adjunct to chemotherapy for adults with de novo acute myeloid leukemia
E Archimbaud, O G Ottmann, J A Yin, et al.
British Journal of Cancer
|
March 17, 2011
Randomised phase II trial of gemcitabine plus vinorelbine vs gemcitabine plus cisplatin vs gemcitabine plus capecitabine in patients with pretreated metastatic breast cancer
H J Stemmler, D diGioia, W Freier, et al.
Blood
|
December 3, 1998
2',5'-Oligoadenylate-antisense chimeras cause RNase L to selectively degrade bcr/abl mRNA in chronic myelogenous leukemia cells
A Maran, C F Waller, J M Paranjape, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 5, 2002
Randomized, controlled, dose-range study of Ro 25-8315 given before and after a high-dose combination chemotherapy regimen in patients with metastatic or recurrent breast cancer patients
P Viens, C Chabannon, P Pouillard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 3, 2004
Rituximab consolidation after high-dose chemotherapy and autologous blood stem cell transplantation in follicular and mantle cell lymphoma: a prospective, multicenter phase II study
W Brugger, J Hirsch, F Grünebach, et al.
Leukemia
|
March 16, 2017
Response-adapted consolidation with bortezomib after ASCT improves progression-free survival in newly diagnosed multiple myeloma
H Einsele, S Knop, M Vogel, et al.
Leukemia
|
April 17, 2012
High activity of sorafenib in FLT3-ITD-positive acute myeloid leukemia synergizes with allo-immune effects to induce sustained responses
S K Metzelder, T Schroeder, A Finck, et al.
Gastroenterology
|
February 9, 2026
Genomic Insights Into Inflammatory Bowel Disease in United States Hispanic Participants: An Ancestry-Focused Study
Ashley H Beecham, Dermot P B McGovern, Steven W Brugger, et al.
Microbiology Resource Announcements
|
February 7, 2024
Complete genome sequences of five <i>Ackermannviridae</i> that infect <i>Enterobacteriaceae</i> hosts
Evan B Harris, Laura B Anthony, Sakhawat Ali, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 18, 2018
Vistusertib (dual m-TORC1/2 inhibitor) in combination with paclitaxel in patients with high-grade serous ovarian and squamous non-small-cell lung cancer
B Basu, M G Krebs, R Sundar, et al.
Page
of 12
Search research articles
Search
Showing results (111-120 of 120) with videos related to
Sort By:
Page
of 12
You have reached the last page of results.
This site can display upto 120 results.
Blood
|
November 26, 1999
A randomized, double-blind, placebo-controlled study with pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) as an adjunct to chemotherapy for adults with de novo acute myeloid leukemia
E Archimbaud, O G Ottmann, J A Yin, et al.
British Journal of Cancer
|
March 17, 2011
Randomised phase II trial of gemcitabine plus vinorelbine vs gemcitabine plus cisplatin vs gemcitabine plus capecitabine in patients with pretreated metastatic breast cancer
H J Stemmler, D diGioia, W Freier, et al.
Blood
|
December 3, 1998
2',5'-Oligoadenylate-antisense chimeras cause RNase L to selectively degrade bcr/abl mRNA in chronic myelogenous leukemia cells
A Maran, C F Waller, J M Paranjape, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 5, 2002
Randomized, controlled, dose-range study of Ro 25-8315 given before and after a high-dose combination chemotherapy regimen in patients with metastatic or recurrent breast cancer patients
P Viens, C Chabannon, P Pouillard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 3, 2004
Rituximab consolidation after high-dose chemotherapy and autologous blood stem cell transplantation in follicular and mantle cell lymphoma: a prospective, multicenter phase II study
W Brugger, J Hirsch, F Grünebach, et al.
Leukemia
|
March 16, 2017
Response-adapted consolidation with bortezomib after ASCT improves progression-free survival in newly diagnosed multiple myeloma
H Einsele, S Knop, M Vogel, et al.
Leukemia
|
April 17, 2012
High activity of sorafenib in FLT3-ITD-positive acute myeloid leukemia synergizes with allo-immune effects to induce sustained responses
S K Metzelder, T Schroeder, A Finck, et al.
Gastroenterology
|
February 9, 2026
Genomic Insights Into Inflammatory Bowel Disease in United States Hispanic Participants: An Ancestry-Focused Study
Ashley H Beecham, Dermot P B McGovern, Steven W Brugger, et al.
Microbiology Resource Announcements
|
February 7, 2024
Complete genome sequences of five <i>Ackermannviridae</i> that infect <i>Enterobacteriaceae</i> hosts
Evan B Harris, Laura B Anthony, Sakhawat Ali, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 18, 2018
Vistusertib (dual m-TORC1/2 inhibitor) in combination with paclitaxel in patients with high-grade serous ovarian and squamous non-small-cell lung cancer
B Basu, M G Krebs, R Sundar, et al.
Page
of 12